Daehan Nupharm Co.,Ltd. (KOSDAQ:054670)
5,980.00
-160.00 (-2.61%)
At close: May 29, 2026
Daehan Nupharm Market Cap
Daehan Nupharm has a market cap or net worth of 83.93 billion as of June 1, 2026. Its market cap has decreased by -13.71% in one year.
Market Cap
83.93B
Enterprise Value
158.10B
Revenue
205.39B
Ranking
n/a
PE Ratio
5.35
Stock Price
5,980.00
Market Cap Chart
Since March 3, 2003, Daehan Nupharm's market cap has increased from 13.03B to 83.93B, an increase of 544.04%. That is a compound annual growth rate of 8.34%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 29, 2026 | 83.93B | -8.98% |
| Dec 30, 2025 | 92.21B | -4.37% |
| Dec 30, 2024 | 96.42B | -24.09% |
| Dec 28, 2023 | 127.02B | 5.97% |
| Dec 29, 2022 | 119.86B | -21.65% |
| Dec 30, 2021 | 152.98B | -13.49% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| H.PIO | 106.08B |
| KOREA PHARMA | 102.96B |
| Organoidsciences | 97.27B |
| WITHUS PHARMACEUTICAL Co.,LTD. | 91.75B |
| Sam-A Pharm. | 88.56B |
| Polaris AI Pharma | 84.88B |
| Pharos iBio | 81.56B |
| Sinsin Pharmaceutical | 76.46B |